Vaccinium oxycoccos (Small Cranberry)
Vaccinium oxycoccos (small cranberry) is a wild berry rich in hydroxycinnamic acid derivatives that demonstrate potent antioxidant activity. These compounds work by neutralizing free radicals and may support periodontal health through antiradical mechanisms.

Origin & History
Vaccinium oxycoccos (small cranberry or European cranberry) is a low-growing evergreen shrub native to northern temperate and boreal regions of Europe, Asia, and North America. The fruit is harvested from wild or cultivated bog habitats and typically processed into extracts, powders, or juice concentrates. This polyphenol-rich plant material derives its bioactivity primarily from anthocyanins, proanthocyanidins, phenolic acids, and triterpene compounds.
Historical & Cultural Context
Small cranberry has a long-standing tradition in folk medicine, particularly in northern European regions. However, the research dossier does not elaborate on specific historical applications, duration of traditional use, or detailed traditional medicine system contexts.
Health Benefits
• Antioxidant protection through hydroxycinnamic acid derivatives (correlation coefficient 0.858, p < 0.01 for reducing activity) - preliminary evidence only • In vitro antiradical activity up to 95.25 ± 1.15 µmol TE/g demonstrated - laboratory studies only • Potential periodontal disease prevention through plaque bacteria adhesion inhibition - preliminary in vitro data • Anti-inflammatory effects suggested through bioactive compound research - no human clinical evidence provided • Antibacterial and antifungal properties reported - based on in vitro studies only
How It Works
Small cranberry's hydroxycinnamic acid derivatives neutralize free radicals through electron donation mechanisms, showing correlation coefficient of 0.858 for reducing activity. These compounds interrupt oxidative stress cascades by scavenging reactive oxygen species and may modulate inflammatory pathways in periodontal tissues.
Scientific Research
The available research consists primarily of phytochemical composition studies and in vitro antioxidant assessments rather than human clinical trials. No randomized controlled trials (RCTs), meta-analyses, or clinical outcome data with PubMed PMIDs were found in the provided research dossier. The evidence base remains at the preliminary stage, focusing on laboratory analysis of bioactive compounds rather than therapeutic effects in humans.
Clinical Summary
Current evidence comes primarily from in vitro laboratory studies demonstrating antiradical activity up to 95.25 ± 1.15 µmol TE/g. The correlation between hydroxycinnamic acid content and antioxidant activity shows statistical significance (p < 0.01). Evidence for periodontal disease prevention remains preliminary with no published human trials. Clinical research in humans is needed to confirm therapeutic applications.
Nutritional Profile
Vaccinium oxycoccos (Small Cranberry) fruits contain approximately 88-90% water. Per 100 g fresh weight: Energy ~46 kcal; Carbohydrates 10-12 g (primarily fructose and glucose, with minimal sucrose); Dietary fiber 3.5-4.5 g (pectin and cellulose); Protein 0.4-0.5 g; Fat 0.1-0.2 g. Vitamin C: 12-30 mg/100 g fresh weight (variable by growing conditions; bioavailability moderate, enhanced by co-occurring flavonoids). Vitamin E (α-tocopherol): ~1.0-1.3 mg/100 g. Minerals: Potassium 70-85 mg, Manganese 0.3-0.5 mg, Calcium 8-10 mg, Magnesium 5-7 mg, Iron 0.2-0.3 mg, Phosphorus 10-13 mg per 100 g. Key bioactive compounds: Total phenolics 300-600 mg GAE/100 g fresh weight; Proanthocyanidins (A-type linkages) 100-250 mg/100 g; Anthocyanins (primarily cyanidin-3-galactoside, peonidin-3-galactoside, cyanidin-3-arabinoside) 50-150 mg/100 g fresh weight; Hydroxycinnamic acid derivatives (chlorogenic acid, caffeic acid, p-coumaric acid) 20-60 mg/100 g; Flavonols including quercetin-3-O-galactoside and myricetin glycosides 15-40 mg/100 g; Benzoic acid 50-100 mg/100 g (natural preservative compound, notably higher than many fruits); Ursolic acid and oleanolic acid (triterpenes) present in fruit skin at approximately 60-120 mg/100 g dry weight. Organic acids: Citric acid 1.5-2.5 g/100 g, malic acid 0.3-0.7 g/100 g, quinic acid 0.5-1.0 g/100 g, contributing to a low pH of ~2.5-2.8. Total sugar content typically 3-6 g/100 g fresh weight. Compared to Vaccinium macrocarpon (American Cranberry), V. oxycoccos generally exhibits higher anthocyanin and proanthocyanidin concentrations per unit weight but smaller fruit size. Bioavailability notes: A-type proanthocyanidins have limited gastrointestinal absorption (estimated <5%), but exert local effects in the urinary tract following renal excretion of metabolites; anthocyanin bioavailability is low (~1-2% intact absorption) though gut microbial metabolites (protocatechuic acid, hippuric acid) may extend biological activity; benzoic acid is well absorbed and excreted as hippuric acid in urine, contributing to urinary acidification.
Preparation & Dosage
No clinically studied dosage ranges for human use were identified in the research. The literature focuses on phytochemical composition analysis with potential standardization markers including chlorogenic acid, cyanidin-3-galactoside, cyanidin-3-arabinoside, and peonidin-3-galactoside, but specific therapeutic dosing protocols are not established. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Vitamin C, bilberry extract, elderberry, quercetin, green tea extract
Safety & Interactions
Small cranberry is generally recognized as safe when consumed as food, with no significant adverse effects reported in traditional use. Potential interactions with anticoagulant medications may exist due to cranberry compounds affecting drug metabolism. Individuals with kidney stones should exercise caution due to oxalate content. Safety during pregnancy and lactation has not been specifically studied for concentrated preparations.